Drew Neavin
Garvan Institute of Medical Research(AU)UNSW Sydney(AU)
Publications by Year
Research Areas
Pluripotent Stem Cells Research, Single-cell and spatial transcriptomics, Tryptophan and brain disorders, Treatment of Major Depression, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases(2018)305 cited
- → TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics(2016)118 cited
- → Single cell eQTL analysis identifies cell type-specific genetic control of gene expression in fibroblasts and reprogrammed induced pluripotent stem cells(2021)116 cited
- → Pharmacogenomics‐Driven Prediction of Antidepressant Treatment Outcomes: A Machine‐Learning Approach With Multi‐trial Replication(2019)106 cited
- → Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression(2021)95 cited
- → Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients(2019)81 cited
- → Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics(2018)76 cited
- → Transcriptomic and proteomic retinal pigment epithelium signatures of age-related macular degeneration(2022)61 cited
- → Demuxafy: improvement in droplet assignment by integrating multiple single-cell demultiplexing and doublet detection methods(2024)59 cited
- → A village in a dish model system for population-scale hiPSC studies(2023)56 cited